330 related articles for article (PubMed ID: 24838298)
1. Molecular targeted therapy in hepatocellular carcinoma: from biology to clinical practice and future.
Patel A; Sun W
Curr Treat Options Oncol; 2014 Sep; 15(3):380-94. PubMed ID: 24838298
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions.
Hilmi M; Neuzillet C; Calderaro J; Lafdil F; Pawlotsky JM; Rousseau B
J Immunother Cancer; 2019 Nov; 7(1):333. PubMed ID: 31783782
[TBL] [Abstract][Full Text] [Related]
3. Emerging targeted strategies in advanced hepatocellular carcinoma.
Finn RS
Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
[TBL] [Abstract][Full Text] [Related]
4. Molecular targeted therapy for hepatocellular carcinoma: current and future.
Shin JW; Chung YH
World J Gastroenterol; 2013 Oct; 19(37):6144-55. PubMed ID: 24115810
[TBL] [Abstract][Full Text] [Related]
5. Clinical trials of antiangiogenic therapy for hepatocellular carcinoma.
Taketomi A
Int J Clin Oncol; 2016 Apr; 21(2):213-218. PubMed ID: 26899258
[TBL] [Abstract][Full Text] [Related]
6. Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications.
Frenette C; Gish R
World J Gastroenterol; 2012 Feb; 18(6):498-506. PubMed ID: 22363115
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy of hepatocellular cancer.
Wysocki PJ
Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
[TBL] [Abstract][Full Text] [Related]
8. Targeted agents and systemic therapy in hepatocellular carcinoma.
Ang C; O'Reilly EM; Abou-Alfa GK
Recent Results Cancer Res; 2013; 190():225-46. PubMed ID: 22941024
[TBL] [Abstract][Full Text] [Related]
9. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
Pang RW; Poon RT
Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic therapies for advanced hepatocellular carcinoma.
Sampat KR; O'Neil B
Oncologist; 2013; 18(4):430-8. PubMed ID: 23576483
[TBL] [Abstract][Full Text] [Related]
11. Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC).
Pazo-Cid RA; Lanzuela M; Esquerdo G; Pérez-Gracia JL; Antón A; Amigo G; Trufero JM; García-Otín AL; Martín-Duque P
Clin Transl Oncol; 2012 Aug; 14(8):564-74. PubMed ID: 22855137
[TBL] [Abstract][Full Text] [Related]
12. Emerging therapies targeting growth factors in hepatocellular carcinoma.
Ruff SM; Pawlik TM
Expert Opin Pharmacother; 2024 Feb; 25(3):255-262. PubMed ID: 38591252
[TBL] [Abstract][Full Text] [Related]
13. Novel drugs in clinical development for hepatocellular carcinoma.
Waidmann O; Trojan J
Expert Opin Investig Drugs; 2015; 24(8):1075-82. PubMed ID: 26108356
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy of hepatocellular carcinoma: present and future.
Chan SL; Yeo W
J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685
[TBL] [Abstract][Full Text] [Related]
15. Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice.
Kudo M
Int J Clin Oncol; 2010 Jun; 15(3):242-55. PubMed ID: 20509038
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
17. Molecular therapies in hepatocellular carcinoma: what can we target?
Galuppo R; Ramaiah D; Ponte OM; Gedaly R
Dig Dis Sci; 2014 Aug; 59(8):1688-97. PubMed ID: 24573715
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma].
Kondo S; Ueno H; Morizane C; Okusaka T
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapies in hepatocellular carcinoma.
Wörns MA; Weinmann A; Schuchmann M; Galle PR
Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
[TBL] [Abstract][Full Text] [Related]
20. Medical Systemic Therapies for Hepatocellular Carcinoma: Clinical Perspectives and Safety Profile.
Facciorusso A; Antonino M; Del Prete V; Amoruso A; Neve V; Barone M
Curr Drug Saf; 2015; 10(3):202-7. PubMed ID: 25994808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]